These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 12715314

  • 1. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
    San-Andrés FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, Costa JR, del Palacio A.
    Clin Infect Dis; 2003 May 01; 36(9):1177-85. PubMed ID: 12715314
    [Abstract] [Full Text] [Related]

  • 2. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ, Gazzard BG, Easterbrook PJ.
    J Infect; 2001 Feb 01; 42(2):134-9. PubMed ID: 11531320
    [Abstract] [Full Text] [Related]

  • 3. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
    Anekthananon T, Ratanasuwan W, Techasathit W, Rongrungruang Y, Suwanagool S.
    J Med Assoc Thai; 2004 Feb 01; 87(2):173-9. PubMed ID: 15061301
    [Abstract] [Full Text] [Related]

  • 4. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome.
    Fisk DT, Meshnick S, Kazanjian PH.
    Clin Infect Dis; 2003 Jan 01; 36(1):70-8. PubMed ID: 12491205
    [Abstract] [Full Text] [Related]

  • 5. Epidemiology and risk of pulmonary disease.
    Rosen MJ.
    Semin Respir Infect; 1999 Dec 01; 14(4):301-8. PubMed ID: 10638509
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pneumocystis carinii pneumonia in the Federal Republic of Germany in the era of changing antiretroviral therapy - IDKF 13 -. German AIDS Study Group (GASG/IdKF).
    Stoehr A, Arasteh K, Staszewski S, Brockmeyer N, Albrecht H, Mertenskötter T, Jablonowski H, Emminger C, Rockstroh JK, Baumgarten R, Bogner J, Loch T, Plettenberg A.
    Eur J Med Res; 1999 Apr 27; 4(4):131-4. PubMed ID: 10205287
    [Abstract] [Full Text] [Related]

  • 9. Discontinuation of secondary prophylaxis for Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients: a randomized trial by the CIOP Study Group.
    Mussini C, Pezzotti P, Antinori A, Borghi V, Monforte Ad, Govoni A, De Luca A, Ammassari A, Mongiardo N, Cerri MC, Bedini A, Beltrami C, Ursitti MA, Bini T, Cossarizza A, Esposito R, Changes in Opportunistic Prophylaxis (CIOP) Study Group.
    Clin Infect Dis; 2003 Mar 01; 36(5):645-51. PubMed ID: 12594647
    [Abstract] [Full Text] [Related]

  • 10. Pneumocystis carinii pneumonia.
    Schliep TC, Yarrish RL.
    Semin Respir Infect; 1999 Dec 01; 14(4):333-43. PubMed ID: 10638513
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR, Kapogiannis BG, Soe MM, Sullivan KM, Abrams E, Farley J, Palumbo P, Koenig LJ, Bulterys M.
    Pediatrics; 2007 Jul 01; 120(1):100-9. PubMed ID: 17606567
    [Abstract] [Full Text] [Related]

  • 16. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 01; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 17. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
    del Giudice P, Mary-Krause M, Pradier C, Grabar S, Dellamonica P, Marty P, Gastaut JA, Costagliola D, Rosenthal E, French Hospital Database on HIV Clinical Epidemiologic Group.
    J Infect Dis; 2002 Nov 01; 186(9):1366-70. PubMed ID: 12402211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL, Vale DA, Magalhães MH.
    J Oral Pathol Med; 2009 Jul 01; 38(6):489-94. PubMed ID: 19453845
    [Abstract] [Full Text] [Related]

  • 20. Discontinuation of Pneumocystis carinii prophylaxis in patients infected with human immunodeficiency virus: a meta-analysis and decision analysis.
    Trikalinos TA, Ioannidis JP.
    Clin Infect Dis; 2001 Dec 01; 33(11):1901-9. PubMed ID: 11692302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.